tezemlimogene daxadenorepvec

AXP000036.1 · Oncolytic virus

Platform
adenovirus (Ad5 Delta-24-RGD, OX40L-armed)
Originator
The University of Texas MD Anderson Cancer Center
Sponsor
DNAtrix

Names

NameTypeSource
tezemlimogene daxadenorepvecpreferred name, INNcurator, ncit
DNX-2440codencit

Virus

Role
Oncolytic
Family
Adenoviridae
Virus
human adenovirus 5 (NCBI Taxonomy 28285)
Strain
Ad5 Delta-24-RGD
Replication
conditionally replicating
Modifications
Delta-24 E1A; RGD-4C fiber; OX40L transgene
Transgenes
TNFSF4
Route
intratumoral, intra arterial
Source
evidence

Cross-references

NCI Thesaurus
C160192
FDA UNII
B7N7BR6M4A

Approvals

No regulatory approval recorded.

Clinical trials (2)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT04714983DNX-2440 for Resectable Colorectal Liver MetastasisSuspendedPhase 12021-02-152026-07-3130Breast Cancer; Colorectal Cancer; Gastric Cancer; Gastrointestinal Stromal Tumors; Liver Metastases; Liver Metastasis Colon Cancer; Melanoma; Periampullary Cancer; Renal Cell Cancer; Sarcoma; Squamous Cell Carcinoma
NCT03714334DNX-2440 Oncolytic Adenovirus for Recurrent GlioblastomaTerminatedPhase 12018-10-162023-04-0516Glioblastoma; Glioblastoma, Adult

Recent changes

No changes recorded in its trials yet.

Clinical papers

No confirmed clinical papers yet.

Other papers

Preclinical studies, reviews and other papers that name it.

PubMedTitleJournalYearLinked by
PMID 34004331Oncolytic viruses as a promising therapeutic strategy against the detrimental health impacts of air pollution: The case of glioblastoma multiforme.Seminars in cancer biology2022name in abstract: DNX-2440

NIH grants

ProjectTitleOrganisationPIYearsLinked by
R44CA268421Phase 1 Study of DNX-2440 for Resectable Colorectal Liver Metastasis - IND 018569DNATRIX, INC.ROBBINS, JOAN MARIE2022–2022name in title: DNX-2440

Notes

DNX-2440: DNX-2401 (AXP000005) backbone armed with OX40L, so a separate program under SPEC section 1. Trials in glioblastoma (NCT03714334) and, by superselective intra-arterial infusion, in liver metastases (NCT04714983).

How to cite

tezemlimogene daxadenorepvec (AXP000036.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000036.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.